Published in Metabolism on January 01, 2008
Stress hyperglycaemia. Lancet (2009) 3.13
Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care (2011) 3.06
Comparison of inpatient insulin regimens with detemir plus aspart versus neutral protamine hagedorn plus regular in medical patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 1.85
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41
Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care (2009) 1.18
Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci (2011) 1.08
Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci (2010) 0.92
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial. Diabetes Care (2015) 0.91
A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms. J Hosp Med (2010) 0.90
Relationship between glycemic control and readmission rates in patients hospitalized with congestive heart failure during implementation of hospital-wide initiatives. Endocr Pract (2011) 0.89
Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen. J Diabetes Sci Technol (2015) 0.80
Impact of hyperglycemia on morbidity and mortality, length of hospitalization and rates of re-hospitalization in a general hospital setting in Brazil. Diabetol Metab Syndr (2010) 0.77
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients. Diabetes Spectr (2014) 0.75
Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest (2007) 7.49
Hyperglycemic crises in adult patients with diabetes. Diabetes Care (2009) 6.01
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care (2009) 5.41
American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Endocr Pract (2009) 3.96
Hyperglycemic crises in adult patients with diabetes: a consensus statement from the American Diabetes Association. Diabetes Care (2006) 3.89
Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med (2012) 3.54
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2016 EXECUTIVE SUMMARY. Endocr Pract (2016) 3.01
American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary. Endocr Pract (2013) 2.97
Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med (2004) 2.47
Hyperglycemic crises in diabetes. Diabetes Care (2004) 2.38
Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes (2004) 2.03
Prevalence and clinical outcome of hyperglycemia in the perioperative period in noncardiac surgery. Diabetes Care (2010) 1.93
Perioperative glucose control in the diabetic or nondiabetic patient. South Med J (2006) 1.87
Hyperglycemic crises in patients with diabetes mellitus. Diabetes Care (2003) 1.61
Thirty years of personal experience in hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. J Clin Endocrinol Metab (2008) 1.56
Safety and efficacy of continuous insulin infusion in noncritical care settings. J Hosp Med (2010) 1.51
Pathways to quality inpatient management of hyperglycemia and diabetes: a call to action. Diabetes Care (2013) 1.51
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Metabolism (2011) 1.41
DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES. Endocr Pract (2017) 1.37
Ketosis-prone type 2 diabetes: time to revise the classification of diabetes. Diabetes Care (2006) 1.37
Hyperglycemia during total parenteral nutrition: an important marker of poor outcome and mortality in hospitalized patients. Diabetes Care (2009) 1.18
Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes (2009) 1.17
Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population. Chest (2005) 1.16
Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care (2004) 1.16
Clinical epidemiology of acute lung injury and acute respiratory distress syndrome: incidence, diagnosis, and outcomes. Clin Chest Med (2006) 1.08
Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am (2012) 1.04
Increased glycemic variability is independently associated with length of stay and mortality in noncritically ill hospitalized patients. Diabetes Care (2013) 1.04
Abdominal pain in patients with hyperglycemic crises. J Crit Care (2002) 1.03
Basal versus sliding-scale regular insulin in hospitalized patients with hyperglycemia during enteral nutrition therapy. Diabetes Care (2009) 1.02
Diabetic ketoacidosis induces in vivo activation of human T-lymphocytes. Biochem Biophys Res Commun (2004) 1.02
Update on diagnosis, pathogenesis and management of ketosis-prone Type 2 diabetes mellitus. Diabetes Manag (Lond) (2011) 1.00
Glycemic control in non-diabetic critically ill patients. Best Pract Res Clin Endocrinol Metab (2011) 1.00
Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. J Diabetes Sci Technol (2012) 1.00
The use of alkali therapy in severe diabetic ketoacidosis. Diabetes Care (2002) 0.99
Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab (2010) 0.99
Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg (2015) 0.99
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS. Endocr Pract (2016) 0.97
Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma. J Am Coll Surg (2010) 0.96
Predictors of mortality in elderly subjects with obstructive airway disease: the PILE score. Ann Epidemiol (2010) 0.95
Predictors of intensive care unit and hospital length of stay in diabetic ketoacidosis. J Crit Care (2002) 0.95
Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. Am J Physiol Endocrinol Metab (2004) 0.93
Management of hyperglycemia in hospitalized patients. Ann N Y Acad Sci (2010) 0.92
Substitution of standard soybean oil with olive oil-based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects. J Clin Endocrinol Metab (2011) 0.91
The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes. Transl Res (2012) 0.91
A comparison study of continuous insulin infusion protocols in the medical intensive care unit: computer-guided vs. standard column-based algorithms. J Hosp Med (2010) 0.90
Changes in serum leptin in lean and obese subjects with acute hyperglycemic crises. J Clin Endocrinol Metab (2003) 0.90
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY. Endocr Pract (2017) 0.90
Obesity-driven inflammation and cancer risk: role of myeloid derived suppressor cells and alternately activated macrophages. Am J Cancer Res (2013) 0.89
Effects of intravenous glucose load on insulin secretion in patients with ketosis-prone diabetes during near-normoglycemia remission. Diabetes Care (2010) 0.89
Management of hyperglycemia in diabetic patients with hematologic malignancies during dexamethasone therapy. Endocr Pract (2013) 0.87
Special considerations on the management of Latino patients with type 2 diabetes mellitus. Curr Med Res Opin (2011) 0.87
Prevalence and clinical outcome of inpatient hyperglycemia in a community pediatric hospital. J Hosp Med (2008) 0.86
Prevalence, quality of care, and complications in long term care residents with diabetes: a multicenter observational study. J Am Med Dir Assoc (2013) 0.85
Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma. Am J Med Sci (2010) 0.85
Update on diabetes in the elderly and in nursing home residents. J Am Med Dir Assoc (2011) 0.85
Diabetic ketoacidosis in type 2 diabetes mellitus--pathophysiology and clinical presentation. Nat Clin Pract Endocrinol Metab (2007) 0.84
Efficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with type 2 diabetes. J Diabetes (2013) 0.84
Rhabdomyolysis in a patient with West Nile encephalitis and flaccid paralysis. Tenn Med (2008) 0.83
Pregnancy complicated by diabetic ketoacidosis: maternal and fetal outcomes. Diabetes Care (2003) 0.82
Contributions of basal and prandial hyperglycemia to total hyperglycemia in older and younger adults with type 2 diabetes mellitus. J Am Geriatr Soc (2013) 0.81
Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep (2013) 0.81
Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusion. J Diabetes Sci Technol (2009) 0.81
CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2015 EXECUTIVE SUMMARY. Endocr Pract (2015) 0.80
Vascular effects of intravenous intralipid and dextrose infusions in obese subjects. Metabolism (2012) 0.80
BASAL-BOLUS REGIMEN WITH INSULIN ANALOGUES VERSUS HUMAN INSULIN IN MEDICAL PATIENTS WITH TYPE 2 DIABETES: A RANDOMIZED CONTROLLED TRIAL IN LATIN AMERICA. Endocr Pract (2015) 0.80
Hyperglycemia is associated with increased hospital complications and mortality during parenteral nutrition. Hosp Pract (1995) (2011) 0.80
Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes. J Clin Endocrinol Metab (2014) 0.80
Do obese children with diabetic ketoacidosis have type 1 or type 2 diabetes? Prim Care Diabetes (2012) 0.79
Oxidative stress and inflammation in hyperglycemic crises and resolution with insulin: implications for the acute and chronic complications of hyperglycemia. J Diabetes Complications (2012) 0.79
How "sweet" complexity is and how "bitter" variability can be; the new aspect of intensive care unit hyperglycemia. Crit Care Med (2010) 0.79
Nebivolol in high-risk, obese African Americans with stage 1 hypertension: effects on blood pressure, vascular compliance, and endothelial function. J Clin Hypertens (Greenwich) (2009) 0.78
Medical nutrition therapy in hospitalized patients with diabetes. Curr Diab Rep (2012) 0.78
Abdominal pathology in patients with diabetes ketoacidosis. Am J Med Sci (2012) 0.78
Diabetes management in urban African Americans: review of a public hospital experience. Ethn Dis (2008) 0.78
Bone mineral density patterns in vitamin D deficient African American men with sickle cell disease. Am J Med Sci (2014) 0.78
Patient guide to managing hyperglycemia (high blood sugar) in the hospital. J Clin Endocrinol Metab (2012) 0.78
Diabetes prevention: can insulin secretagogues do the job? Prim Care Diabetes (2010) 0.77
Time-dependent glycemic variability and mortality in critically ill patients with diabetes. Crit Care Med (2011) 0.77
Metformin-associated lactic acidosis. Am J Med Sci (2015) 0.77
[Management of hyperglycemia in the hospitalized patient]. Medicina (B Aires) (2010) 0.77
Methylprednisolone infusion in early severe ARDS results of a randomized controlled trial. 2007. Chest (2009) 0.77
Dual time point positron emission tomography/computed tomography scan in evaluation of intrathoracic lesions in an area endemic for histoplasmosis and with high prevalence of sarcoidosis. Am J Med Sci (2013) 0.77
Practical implementation of incretin-based therapy in hospitalized patients with type 2 diabetes. Postgrad Med (2014) 0.76
Perioperative Hyperglycemia Management: An Update. Anesthesiology (2017) 0.75
Intravenous gammaglobulin as rescue therapy in a patient with sickle cell and septic shock. Tenn Med (2013) 0.75
Intensive care unit (short) and 1-year (long-term) prognosis: data are in for patients with ischemic stroke. Crit Care Med (2009) 0.75
The ICU "golden hour" vs morning admissions: do they compete? Chest (2009) 0.75
Insulin resistance and pubertal changes. J Clin Endocrinol Metab (2008) 0.75
Multiplicative surrogate standard deviation: a group metric for the glycemic variability of individual hospitalized patients. J Diabetes Sci Technol (2013) 0.75
Parenteral nutrition: lipid (soybean) versus lipid (olive oil); same… or maybe not? Crit Care Med (2012) 0.75
Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes. J Diabetes Complications (2013) 0.75
Pharmacotherapy for Hyperglycemia in Noncritically Ill Hospitalized Patients. Diabetes Spectr (2014) 0.75
Hypoglycemia risk: a cause for concern in the intensive care unit hyperglycemia control debate. Crit Care Med (2007) 0.75
Erratum: efficacy and safety of dulaglutide versus sitagliptin after 52 weeks in type 2 diabetes in a randomized controlled trial (AWARD-5). Diabetes Care 2014;37:2149-2158. Diabetes Care (2015) 0.75
Diabetic ketoacidosis presenting with acute pancreatitis and visceral vein thrombosis. Tenn Med (2011) 0.75
PERSPECTIVES ON LEARNING AND CLINICAL PRACTICE IMPROVEMENT FOR DIABETES IN THE HOSPITAL: A REVIEW OF EDUCATIONAL INTERVENTIONS FOR PROVIDERS. Endocr Pract (2017) 0.75
Lung scedosporiosis in human immunodeficiency virus/acquired immunodeficiency syndrome. Am J Med Sci (2010) 0.75
Psychiatric disorder does not preclude adequate continuous positive airway pressure titration. Am J Med Sci (2013) 0.75